![Schuyler Vinzant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Schuyler Vinzant formerly worked at Krystal Biotech, Inc., as Senior Director-Regulatory & Clinical Operations and Adial Pharmaceuticals, Inc., as Vice President-Development from 2020 to 2023.
Mr. Vinzant received his undergraduate degree from George Mason University.
| Sociétés | Poste | Fin |
|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2023 |
| KRYSTAL BIOTECH, INC. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Adial Pharmaceuticals, Inc.
 Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
George Mason University
 George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
 Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
